EMBARGOED UNTIL 11 FEBRUARY 2005
Improving communication about sexual health during the menopause
On Friday 11 February at 10.30am, the British Menopause Society and the Royal Society of Medicine Press will launch a new publication, Sexual Health and the Menopause at the RSM’s headquarters at 1 Wimpole Street in London.
The book, edited by John M Tomlinson, Margaret Rees and
Tony Mander, provides up-to-date information on sexual
health issues involving both women and men during the peri-menopause.
Aimed at General Practitioners and other healthcare professionals,
the contributors bring together information throughout
many specialties to offer the first comprehensive, cross-disciplinary
publication to address the previously sensitive subject
of sexual health during this time in a woman’s life.
The book is designed to outline the various relevant issues
and enhance communication between doctors and their patients,
therefore increasing the quality and comfort of care.
Keeping sex alive: maintaining sexual health and desire
in the later years
The contributors emphasise the importance of maintaining
a healthy sex life as women enter the menopause. Suggestions
for opening lines of communication between patients and
their partners are discussed as well as advice in dealing
with the natural hormonal changes that occur during the
menopause.
Sexual problems and dysfunction
There are a number of things that can go wrong during the
menopause, including a drop in sexual desire, psychological
discomfort and pain disorders such as dyspareunia. Two
contributors discuss the types of problems and identify
some causes and ways to manage within the primary care
setting.
Sex therapy: how the patient can learn to help herself
Another chapter talks about psychosexual therapy and self-help
options to empower women to seek alternative ways to deal
with their sexual problems. Methods include talking with
a sex therapist and encouraging women to educate themselves
about issues they may be unsure of. The author also suggests
a number of sex aids that may be of use in improving an
ailing sex life.
Drug treatments
Pharmacotherapy treatments have shown varied results in
completed studies. Androgen replacement therapies, such
as testosterone therapy and tibolone steroid agents, have
shown positive results in clinical trials, the authors
write. Vaginal oestrogens, a non-testosterone-based treatment
is an effective for vaginal dryness and dyspareunia and
cause no adverse endometrial effects. Sildenafil, a drug
commonly used to treat erectile dysfunction, is undergoing
research to treat female sexual arousal disorder but results
are inconclusive. Bupropion, an antidepressant, have shown
promising results in small, limited trials.
Risk of HIV and other STI infection during and after
the menopause
The rates of STI and HIV infection are on the rise in adults
over the age of 45, with the most ‘rapidly growing
group of patients’ acquiring infection through heterosexual
contact. In spite of this, they are ‘universally
omitted from prevention programmes’ and, although
patients in this age group are physiologically predisposed
to STI infection and diagnostic techniques are often muddled
by the presence of other age-related conditions and natural
changes in the body, menopausal women have ‘largely
been ignored within the field of sexual health.’ For
further information on this chapter, please email the address
below.
[ends]
Note to editors:
About the BMS
The British Menopause Society (BMS) is a registered charity aimed at the medical profession and is open to healthcare
professionals specialising in the menopause, including
consultants, trainee gynaecologists, GPs and nursing professionals.
BMS aims to increase the awareness of post-menopausal healthcare
issues and promote optimal management through its conferences,
road shows and publications.
